EUVIMEDEUVIMED entdecken
Crossref

Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma

Carrie Printz

CA: A Cancer Journal for Clinicians · 2026-03 · 76 (2)

DOI: 10.3322/caac.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 20.04.2026. Verfasst von Carrie Printz. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Printz, C. (2026). Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma. CA: A Cancer Journal for Clinicians, 76(2). https://doi.org/10.3322/caac.70078

Vancouver

Printz C. Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma. CA: A Cancer Journal for Clinicians. 2026;76(2). doi:10.3322/caac.70078

BibTeX
@article{Printz2026,
  author = {Printz, Carrie},
  title = {Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma},
  journal = {CA: A Cancer Journal for Clinicians},
  year = {2026},
  volume = {76},
  number = {2},
  doi = {10.3322/caac.70078}
}
Kostenlos starten →